Pharmaceutical compositions comprising an activated form combined Enhanced Antibody against s-100 Protein and an activated form of Brain Enhanced endothelial Antibodies against US； method of treatment of Motion Sickness and vertigo Vegetative vascular dystonia.
The present invention relates to combination pharmaceutical compositions comprising an activated-potentiated form of an antibody to endothelial NO synthase and activated potentiated form of an antibody to brain-specific protein S-100 and its use for the treatment of vegetative-vascular dystonia (VVD) and symptoms thereof.La presente solicitud propone una combinación farmacéutica que comprende una mezcla de disoluciones en un factor de 100^12, 100^30 y 100^200 de un anticuerpo para la proteína S-100 específica de cerebro y una mezcla de disoluciones en un factor de 100^12, 100^30 y 100^200 de un anticuerpo para la óxido nítrico sintasa endotelial (eNOS)； y su uso para preparar un medicamento útil para el tratamiento del vértigo, la cinetosis y la distonía vascular vegetativa.
